Journals / Ankara Üniversitesi Eczacılık Fakültesi Dergisi / 2021 / Cilt: 45 - Sayı: 1

THE ROLE OF THE PHARMACIST IN HYPERTENSION MANAGEMENT: A MODEL APPLICATION IN PRIMARY HEALTH CARE

HİPERTANSIYON TEDAVİ YÖNETİMİNDE ECZACININ ROLÜ: AİLE SAĞLIĞI MERKEZİ’NDE BİR MODEL UYGULAMASI

Pages
1–11
Publication Date
2021-01-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This study revealed the active role and the requirement of the presence of a pharmacist in addition to other health care providers in PHCs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Pharmacists have important roles in pharmaceutical care practices.
📊
Key Findings & Data:A post-test was done three months after the pre-test in order to assess the efficiency of the education.Result and Discussion: In total, 103 patients (70.9% female; mean age: 62.84 ± 10.44 years) were analysed before and after receiving counselling from two pharmacists.
💡
Conclusion & Impact:This study revealed the active role and the requirement of the presence of a pharmacist in addition to other health care providers in PHCs.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Hypertension · pharmaceutical care · pharmacist

Abstract

Objective: Pharmacists have important roles in pharmaceutical care practices. In this study, it was aimed to investigate the potential benefits of the presence of a pharmacist in PHCs (Primary Health Care) in addition to other health care specialists in Ankara Kecioren Karargahtepe PHC and Ankara Ayas PHC.Material and Method: This study is a quasi-experimental type of study which includes a pre-test and a post-test. Pre-test was given to patients by two pharmacists, which was followed by a basic education on hypertension and its treatment. A post-test was done three months after the pre-test in order to assess the efficiency of the education.Result and Discussion: In total, 103 patients (70.9% female; mean age: 62.84 ± 10.44 years) were analysed before and after receiving counselling from two pharmacists. The results of pre- and post-tests were analyzed by Wilcoxon t-test using SPSS 23.0. As a result of the statistical analysis, the education provided by the pharmacists enhanced the mean patient scores significantly (T0 (pre-test) = 6 (5-7), T1 (post-test) = 8 (6-9); P ˂ 0.05). This study revealed the active role and the requirement of the presence of a pharmacist in addition to other health care providers in PHCs.

Özet

Amaç: Farmasötik bakım uygulamalarında eczacılar önemli rol oynamaktadır. Bu çalışmada Aile Sağlığı Merkezi’nde bulunan diğer sağlık personellerinin yanı sıra eczacı varlığının potansiyel yararları incelenmiştir.

🔖

Cite This Article

PEHLİVANLI, A., AKYOL, B., DEMİREL, Ö., GÖÇÜN, Ö., BEŞİKÇİ, A. O., ÖZÇELİKAY, A. T., ÖZÇELİKAY, G. (2021). THE ROLE OF THE PHARMACIST IN HYPERTENSION MANAGEMENT: A MODEL APPLICATION IN PRIMARY HEALTH CARE. Ankara Üniversitesi Eczacılık Fakültesi Dergisi, Cilt: 45 - Sayı: 1, 1–11. https://ajindex.com/articles/83242

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Türk Eczacıları Birliği. Türkiye'de Aile Hekimliği Uygulamasına Genel Bakış: Türk Eczacıları Birliği Raporu. In: Türkiye’de Aile Hekimliği Uygulamaları ve Serbest Eczacılara Yansımaları 2009. Retrieved June 18, 2018, from
  2. Van Mil, J.W., Fernandez-Llimos, F. (2013). What is 'pharmaceutical care' in 2013? Pharm Pract (Granada), 11(1), 1–2
  3. Conference of Experts on the Rational Use of Drugs (1985: Nairobi). (1987). The rational use of drugs: report of the Conference of Experts, Nairobi, 25-29 November 1985. World Health Organization, Retrieved June 18, 2018, from
  4. Toklu, H.Z., Dülger, G. (2010). Eczacılar için akılcı ilaç kullanımı eğitimi. Sentez, 6, 16-17
  5. Cazarim, MdS., Freitas, Od., Penaforte, T.R., Achcar, A., Pereira, LRL. (2016). Impact assessment of pharmaceutical care in the management of hypertension and coronary risk factors after discharge. PLoS One, 11(6), e0155204
  6. Kearney, PM., Whelton, M., Reynold, K., Muntner P, Whelton PK, He J. (2005). Global burden of hypertension: analysis of worldwide data. Lancet, 365(9455), 217-223
  7. World Health Organization, 2003. Adherence to long-term therapies: evidence for action / [edited by Eduardo Sabaté]. Retrieved June 18, 2018, from
  8. Fulton, M.M., Allen, E.R. (2005). Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract., 17(4), 123–132
  9. Finkers, F., Maring, J.G., Boersma, F., Taxis, K. (2007). A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting. J Clin Pharm Ther., 32(5), 469–476
  10. Morgado, M., Rolo, S., Castelo-Branco, M. (2011). Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm., 33(1), 132-140
  11. Omboni, S., Sala, E. (2015). The pharmacist and the management of arterial hypertension: the role of blood pressure monitoring and telemonitoring. Expert Rev Cardiovasc Ther., 13(2), 209-221
  12. Green, B.B., Cook, A.J., Ralston, J.D., Fishman, P.A., Catz, S.L., Carlson, J., Carrell, D., Tyll, L., Larson, E.B., Thompson, R.S. (2008). Effectiveness of home blood pressure monitoring, web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA, 299(24), 2857–2867
  13. Bogden, P.E., Abbott, R.D., Williamson, P., Onopa, J.K., Koontz, L.M. (1998). Comparin